← Back to Vaccine Database

MVA-BN-filo + Ad26. ZEBOV

Viral vector (Non-replicating) vaccine · VDDBV0525

Target & Classification

EBOVEbola virus
Viral vector (Non-replicating) vaccine
Ebola Virus Disease
Phase 2

Clinical Development

Phase 1
Phase 2
Phase 3
Approved

Clinical Trials5

Note: 4 additional source trials listed this vaccine in studies of unrelated viruses (e.g. as a comparator, adjunct, or in coadministration trials with other vaccines). Those trials are not shown here.

NCT IDPhaseDisease / Condition
NCT02313077 Phase 1Ebola Virus Disease
NCT02325050 Phase 1Ebola Virus Disease
NCT02416453 Phase 2Ebola Virus Disease
NCT02376426 Phase 1Ebola Virus Disease
NCT02376400 Phase 1Ebola Virus Disease